Big Pharma

Understanding oral bacteria to help fight periodontal disease

Understanding oral bacteria to help fight periodontal disease

Understanding oral bacteria to help fight periodontal disease Wilfrid Laurier researchers are exploring how bacteria target weak points in the connective ligaments in your mouth. Using the extremely brilliant light of the Canadian Light Source at the University of Saskatchewan, researchers from Wilfrid Laurier University have advanced our understanding of how a specific group of bacteria in the human mouth contribute to periodontal disease. Dr. Michael Suits and his colleagues were focused on a group of three different bacteria — commonly referred to as the “red complex” — as key contributors to infections and inflammation of the gums and bones...

Leer más →


Serum TDP-43 levels can help to identify common neuropathological changes associated with frontotemporal dementia

Serum TDP-43 levels can help to identify common neuropathological changes associated with frontotemporal dementia

Serum TDP-43 levels can help to identify common neuropathological changes associated with frontotemporal dementia Frontotemporal dementia (FTD) is one of the most common causes of progressive dementia in working-age people. However, making a diagnosis and a prognosis is often challenging because the frontotemporal dementia spectrum includes several subtypes that differ in terms of symptoms, genetics and neuropathology, i.e., changes in the brain associated with the disease. Typically, proteins accumulating in the brain of patients with FTD and harming their neurons are either TDP-43 or tau proteins. Understanding the neuropathological changes in patients already at the diagnostic stage would be particularly...

Leer más →


INIFY Laboratories - Laboratory and recruitment on track with positive market feedback

INIFY Laboratories - Laboratory and recruitment on track with positive market feedback

INIFY Laboratories - Laboratory and recruitment on track with positive market feedback STOCKHOLM – October 26, 2022 – Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated on Campus Solna close to Karolinska Institutet in Stockholm. “In an impressively short time, we have built a simulation lab where we further improve, test and verify our development work, ensuring that it fits well into the upcoming production environment,” says CEO Fredrik Palm at Inify Laboratories. The system has an optimized and standardized workflow for pathological...

Leer más →


Plastic Surgery Bundling Booms But Beware

Plastic Surgery Bundling Booms But Beware

Plastic Surgery Bundling Booms But Beware     New York, NY, October, 2022 — Social media, cell phone cameras and video conferencing apps like Zoom and Teams drove a significant uptick in facial plastic surgeries over the past couple of years. Now, the trend is pivoting back to the body, says top New York City plastic surgeon Dr. Richard Westreich.   “Body contouring is surging and in demand,” said Dr. Westreich. “Now that we're getting a level of normalcy, the boom from Zoom is switching back to focusing on the body.”    Also on trend? Bundling more than one procedure in...

Leer más →


One in three Alzheimer’s disease family caregivers has persistent symptoms of depression

One in three Alzheimer’s disease family caregivers has persistent symptoms of depression

One in three Alzheimer’s disease family caregivers has persistent symptoms of depression More than 60% of family caregivers of individuals with Alzheimer’s disease (AD) experienced at least mild depressive symptoms already at the time the individual with AD was diagnosed. In one third of them, depressive symptoms worsened during a five-year follow-up.               The study carried out at the University of Eastern Finland included 226 family caregivers of individuals with AD. Depressive symptoms experienced by family caregivers were monitored for five years, starting from the diagnosis of the individual with AD. 61.5% of family caregivers experienced depressive symptoms at the time...

Leer más →